DrugPatentWatch Database Preview
Drugs in MeSH Category Sodium Channel Blockers
» See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Micro Labs | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 211745-002 | Feb 27, 2020 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Sunshine | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 211865-001 | Mar 23, 2020 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Cipla | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 211291-001 | May 28, 2019 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |